Concepts (223)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pregnancy Complications, Infectious | 11 | 2024 | 2125 | 2.510 |
Why?
|
Pain, Postoperative | 8 | 2019 | 1721 | 2.150 |
Why?
|
Cesarean Section | 7 | 2021 | 1385 | 2.040 |
Why?
|
Labor, Obstetric | 2 | 2023 | 321 | 1.270 |
Why?
|
Hepatitis B | 3 | 2023 | 701 | 1.160 |
Why?
|
Pregnancy | 39 | 2024 | 29749 | 1.060 |
Why?
|
Hepatitis B Vaccines | 3 | 2023 | 186 | 0.940 |
Why?
|
Hypertension, Pregnancy-Induced | 4 | 2022 | 518 | 0.900 |
Why?
|
Analgesics, Opioid | 5 | 2019 | 3763 | 0.840 |
Why?
|
Puerperal Disorders | 3 | 2024 | 300 | 0.820 |
Why?
|
Fetal Membranes, Premature Rupture | 1 | 2023 | 137 | 0.800 |
Why?
|
Chorioamnionitis | 1 | 2023 | 156 | 0.790 |
Why?
|
Antibody Formation | 2 | 2022 | 1400 | 0.740 |
Why?
|
Vaccination | 8 | 2023 | 3361 | 0.710 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2022 | 252 | 0.700 |
Why?
|
Fetal Blood | 2 | 2022 | 1343 | 0.620 |
Why?
|
Bupivacaine | 2 | 2018 | 413 | 0.610 |
Why?
|
Mass Screening | 4 | 2022 | 5423 | 0.600 |
Why?
|
Delivery, Obstetric | 3 | 2021 | 932 | 0.590 |
Why?
|
Prenatal Care | 2 | 2022 | 1129 | 0.560 |
Why?
|
Immunoglobulin G | 4 | 2022 | 4541 | 0.540 |
Why?
|
Gynecology | 1 | 2022 | 528 | 0.520 |
Why?
|
Inappropriate Prescribing | 1 | 2018 | 209 | 0.510 |
Why?
|
Cannabis | 1 | 2022 | 436 | 0.510 |
Why?
|
Cost-Benefit Analysis | 3 | 2024 | 5508 | 0.490 |
Why?
|
Infertility | 1 | 2022 | 655 | 0.490 |
Why?
|
Emergency Treatment | 1 | 2019 | 498 | 0.490 |
Why?
|
Maternal Health Services | 1 | 2020 | 455 | 0.480 |
Why?
|
Liposomes | 1 | 2018 | 777 | 0.470 |
Why?
|
Gynecologic Surgical Procedures | 1 | 2017 | 304 | 0.460 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2017 | 488 | 0.460 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2017 | 370 | 0.460 |
Why?
|
Prenatal Diagnosis | 2 | 2024 | 1264 | 0.450 |
Why?
|
Sweet Syndrome | 2 | 2024 | 58 | 0.450 |
Why?
|
Fever | 3 | 2024 | 1617 | 0.450 |
Why?
|
Placenta | 2 | 2022 | 1702 | 0.440 |
Why?
|
Acetaminophen | 1 | 2017 | 553 | 0.430 |
Why?
|
Epidemiologic Methods | 1 | 2017 | 1343 | 0.420 |
Why?
|
Postpartum Period | 3 | 2024 | 1167 | 0.410 |
Why?
|
Decision Support Techniques | 3 | 2024 | 2001 | 0.410 |
Why?
|
Narcotic Antagonists | 1 | 2017 | 583 | 0.410 |
Why?
|
Antibodies, Viral | 3 | 2023 | 3143 | 0.410 |
Why?
|
Fetal Diseases | 1 | 2017 | 911 | 0.400 |
Why?
|
Rickettsia Infections | 1 | 2011 | 8 | 0.390 |
Why?
|
Anesthetics, Local | 1 | 2018 | 1001 | 0.380 |
Why?
|
Q Fever | 1 | 2011 | 38 | 0.370 |
Why?
|
Female | 47 | 2024 | 391270 | 0.370 |
Why?
|
Papillomavirus Vaccines | 1 | 2016 | 495 | 0.350 |
Why?
|
Markov Chains | 2 | 2024 | 968 | 0.330 |
Why?
|
Spouse Abuse | 1 | 2011 | 179 | 0.330 |
Why?
|
Medically Underserved Area | 1 | 2011 | 257 | 0.310 |
Why?
|
Immunoglobulin M | 3 | 2022 | 1529 | 0.310 |
Why?
|
Data Collection | 1 | 2017 | 3315 | 0.310 |
Why?
|
Anemia | 1 | 2017 | 1511 | 0.280 |
Why?
|
Infectious Disease Transmission, Vertical | 3 | 2024 | 1348 | 0.280 |
Why?
|
Humans | 49 | 2024 | 760621 | 0.270 |
Why?
|
Research Design | 1 | 2022 | 6180 | 0.260 |
Why?
|
Opioid-Related Disorders | 2 | 2019 | 2138 | 0.260 |
Why?
|
Hemorrhage | 1 | 2017 | 3600 | 0.250 |
Why?
|
Hypertension | 2 | 2023 | 8594 | 0.250 |
Why?
|
Infant, Newborn | 9 | 2023 | 26181 | 0.250 |
Why?
|
HIV Seropositivity | 1 | 2011 | 955 | 0.250 |
Why?
|
Pregnancy Outcome | 3 | 2024 | 2907 | 0.230 |
Why?
|
Adult | 21 | 2024 | 219994 | 0.230 |
Why?
|
Opiate Substitution Treatment | 2 | 2019 | 436 | 0.230 |
Why?
|
Anti-Bacterial Agents | 2 | 2024 | 7408 | 0.220 |
Why?
|
Embryo Transfer | 3 | 2022 | 522 | 0.220 |
Why?
|
Tetanus | 1 | 2023 | 51 | 0.220 |
Why?
|
Diphtheria | 1 | 2023 | 33 | 0.220 |
Why?
|
Pregnancy Complications | 3 | 2024 | 2942 | 0.220 |
Why?
|
Skin Ulcer | 1 | 2024 | 129 | 0.210 |
Why?
|
Eclampsia | 1 | 2023 | 56 | 0.210 |
Why?
|
Pregnant Women | 3 | 2022 | 563 | 0.200 |
Why?
|
Decision Making | 2 | 2018 | 3925 | 0.200 |
Why?
|
Hepatitis B Antibodies | 1 | 2022 | 157 | 0.190 |
Why?
|
Women's Health | 1 | 2011 | 2056 | 0.190 |
Why?
|
Analgesia, Obstetrical | 2 | 2021 | 169 | 0.190 |
Why?
|
Vital Signs | 1 | 2022 | 144 | 0.180 |
Why?
|
Pregnancy, Multiple | 1 | 2021 | 215 | 0.180 |
Why?
|
Clinical Trials as Topic | 1 | 2016 | 8056 | 0.180 |
Why?
|
Carotid Artery, Internal, Dissection | 1 | 2020 | 42 | 0.180 |
Why?
|
Vertebral Artery Dissection | 1 | 2020 | 51 | 0.170 |
Why?
|
Immunization, Secondary | 1 | 2022 | 368 | 0.170 |
Why?
|
Hepatitis B, Chronic | 1 | 2023 | 403 | 0.170 |
Why?
|
Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2019 | 29 | 0.160 |
Why?
|
Immunoglobulin A | 1 | 2022 | 979 | 0.160 |
Why?
|
Transportation | 1 | 2020 | 214 | 0.160 |
Why?
|
Quality-Adjusted Life Years | 2 | 2024 | 1724 | 0.160 |
Why?
|
Blood Pressure Determination | 1 | 2022 | 640 | 0.150 |
Why?
|
Progesterone | 1 | 2022 | 742 | 0.150 |
Why?
|
Retrospective Studies | 11 | 2022 | 80372 | 0.150 |
Why?
|
Uterine Diseases | 1 | 2019 | 117 | 0.150 |
Why?
|
Term Birth | 1 | 2018 | 140 | 0.150 |
Why?
|
Abdominal Pain | 1 | 2024 | 1063 | 0.150 |
Why?
|
Models, Economic | 1 | 2022 | 719 | 0.150 |
Why?
|
Oocyte Retrieval | 1 | 2018 | 158 | 0.140 |
Why?
|
Logistic Models | 3 | 2018 | 13314 | 0.140 |
Why?
|
Fertility | 1 | 2022 | 773 | 0.140 |
Why?
|
Self Care | 1 | 2022 | 793 | 0.140 |
Why?
|
Fertilization in Vitro | 2 | 2022 | 1292 | 0.140 |
Why?
|
Monte Carlo Method | 1 | 2022 | 1257 | 0.140 |
Why?
|
Tanzania | 2 | 2011 | 1383 | 0.140 |
Why?
|
Odds Ratio | 2 | 2018 | 9716 | 0.130 |
Why?
|
Gestational Age | 2 | 2022 | 3565 | 0.130 |
Why?
|
Parity | 1 | 2018 | 925 | 0.120 |
Why?
|
Single-Blind Method | 1 | 2018 | 1578 | 0.120 |
Why?
|
Infant | 4 | 2023 | 36060 | 0.120 |
Why?
|
Pre-Eclampsia | 1 | 2023 | 1229 | 0.110 |
Why?
|
United States | 6 | 2022 | 72461 | 0.110 |
Why?
|
Ischemia | 1 | 2022 | 1893 | 0.110 |
Why?
|
Young Adult | 9 | 2021 | 58741 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3085 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3205 | 0.100 |
Why?
|
Rickettsia conorii | 1 | 2011 | 1 | 0.100 |
Why?
|
Rickettsia typhi | 1 | 2011 | 5 | 0.100 |
Why?
|
Bacteremia | 1 | 2019 | 980 | 0.100 |
Why?
|
India | 1 | 2018 | 2336 | 0.100 |
Why?
|
Drug Resistance, Bacterial | 1 | 2019 | 1055 | 0.100 |
Why?
|
Coxiella burnetii | 1 | 2011 | 37 | 0.090 |
Why?
|
Genetic Testing | 1 | 2024 | 3531 | 0.090 |
Why?
|
Prospective Studies | 3 | 2022 | 54303 | 0.090 |
Why?
|
Residence Characteristics | 1 | 2020 | 2062 | 0.090 |
Why?
|
World Health Organization | 1 | 2016 | 1312 | 0.090 |
Why?
|
Obstetrics | 1 | 2017 | 667 | 0.090 |
Why?
|
Birth Weight | 1 | 2018 | 2097 | 0.090 |
Why?
|
Guidelines as Topic | 1 | 2016 | 1392 | 0.090 |
Why?
|
Case-Control Studies | 3 | 2022 | 22053 | 0.080 |
Why?
|
Marital Status | 1 | 2011 | 433 | 0.080 |
Why?
|
Sepsis | 1 | 2023 | 2592 | 0.080 |
Why?
|
Premature Birth | 1 | 2021 | 1771 | 0.080 |
Why?
|
Unemployment | 1 | 2011 | 209 | 0.080 |
Why?
|
Drug Prescriptions | 1 | 2018 | 1673 | 0.080 |
Why?
|
Personal Autonomy | 1 | 2011 | 302 | 0.080 |
Why?
|
Pain Measurement | 1 | 2018 | 3528 | 0.080 |
Why?
|
HIV Infections | 2 | 2011 | 17165 | 0.070 |
Why?
|
Critical Care | 1 | 2020 | 2699 | 0.070 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 2282 | 0.070 |
Why?
|
Ambulatory Care | 1 | 2018 | 2781 | 0.070 |
Why?
|
Prevalence | 3 | 2020 | 15687 | 0.070 |
Why?
|
Blood Pressure | 1 | 2022 | 8525 | 0.070 |
Why?
|
RNA, Messenger | 1 | 2021 | 12766 | 0.070 |
Why?
|
Adolescent | 6 | 2020 | 87810 | 0.070 |
Why?
|
Predictive Value of Tests | 1 | 2022 | 15289 | 0.060 |
Why?
|
Ethics, Medical | 1 | 2011 | 783 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2017 | 3696 | 0.060 |
Why?
|
Patient Discharge | 1 | 2018 | 3476 | 0.060 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 3465 | 0.060 |
Why?
|
Suppuration | 1 | 2024 | 61 | 0.060 |
Why?
|
Health Resources | 1 | 2011 | 935 | 0.060 |
Why?
|
Dapsone | 1 | 2024 | 56 | 0.060 |
Why?
|
Cohort Studies | 3 | 2022 | 41335 | 0.060 |
Why?
|
Perinatology | 1 | 2023 | 62 | 0.060 |
Why?
|
Magnesium Sulfate | 1 | 2023 | 73 | 0.050 |
Why?
|
Educational Status | 1 | 2011 | 2515 | 0.050 |
Why?
|
Quality Improvement | 1 | 2018 | 3836 | 0.050 |
Why?
|
Hepatitis B Surface Antigens | 1 | 2023 | 301 | 0.050 |
Why?
|
Treatment Outcome | 2 | 2018 | 65017 | 0.050 |
Why?
|
Chemokine CXCL10 | 1 | 2022 | 316 | 0.050 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2022 | 298 | 0.050 |
Why?
|
Acute Disease | 1 | 2011 | 7269 | 0.040 |
Why?
|
Risk Factors | 3 | 2021 | 74359 | 0.040 |
Why?
|
Interleukin-18 | 1 | 2022 | 251 | 0.040 |
Why?
|
Hepatitis B virus | 1 | 2023 | 522 | 0.040 |
Why?
|
Genes, BRCA1 | 1 | 2024 | 765 | 0.040 |
Why?
|
Pregnancy, High-Risk | 1 | 2020 | 119 | 0.040 |
Why?
|
National Institute of Child Health and Human Development (U.S.) | 1 | 2019 | 24 | 0.040 |
Why?
|
Advisory Committees | 1 | 2023 | 788 | 0.040 |
Why?
|
Interleukin-8 | 1 | 2022 | 698 | 0.040 |
Why?
|
Inflammation | 1 | 2019 | 10756 | 0.040 |
Why?
|
Anesthesia, Obstetrical | 1 | 2021 | 233 | 0.040 |
Why?
|
Pregnancy Rate | 1 | 2022 | 649 | 0.040 |
Why?
|
Drainage | 1 | 2024 | 1161 | 0.040 |
Why?
|
Uncertainty | 1 | 2023 | 754 | 0.040 |
Why?
|
New York City | 1 | 2020 | 724 | 0.040 |
Why?
|
Peripartum Period | 1 | 2019 | 138 | 0.040 |
Why?
|
Neonatal Abstinence Syndrome | 1 | 2019 | 108 | 0.040 |
Why?
|
Patient Positioning | 1 | 2020 | 327 | 0.040 |
Why?
|
BRCA1 Protein | 1 | 2024 | 1147 | 0.040 |
Why?
|
Middle Aged | 5 | 2024 | 220352 | 0.040 |
Why?
|
Decision Trees | 1 | 2019 | 506 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39261 | 0.030 |
Why?
|
Cryopreservation | 1 | 2022 | 717 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2024 | 21025 | 0.030 |
Why?
|
Substance Abuse Detection | 1 | 2019 | 301 | 0.030 |
Why?
|
Education | 1 | 2019 | 534 | 0.030 |
Why?
|
Estradiol | 1 | 2022 | 1932 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2024 | 1869 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 749 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2024 | 2145 | 0.030 |
Why?
|
Anesthesia, General | 1 | 2021 | 1166 | 0.030 |
Why?
|
Age Factors | 1 | 2011 | 18416 | 0.030 |
Why?
|
Antibodies, Neutralizing | 1 | 2023 | 1933 | 0.030 |
Why?
|
Consensus | 1 | 2023 | 3113 | 0.030 |
Why?
|
Thromboembolism | 1 | 2020 | 1017 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2023 | 2061 | 0.030 |
Why?
|
Infertility, Female | 1 | 2018 | 759 | 0.030 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7475 | 0.020 |
Why?
|
Infant, Premature | 1 | 2021 | 2092 | 0.020 |
Why?
|
Hospitalization | 1 | 2011 | 10790 | 0.020 |
Why?
|
Breast Feeding | 1 | 2019 | 1355 | 0.020 |
Why?
|
Seizures | 1 | 2023 | 2917 | 0.020 |
Why?
|
Pandemics | 2 | 2020 | 8624 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2011 | 25942 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2024 | 3202 | 0.020 |
Why?
|
Male | 2 | 2022 | 359744 | 0.020 |
Why?
|
Risk Assessment | 2 | 2021 | 24123 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2024 | 12965 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2020 | 1830 | 0.020 |
Why?
|
Child | 2 | 2020 | 79806 | 0.020 |
Why?
|
Child, Preschool | 1 | 2011 | 42063 | 0.020 |
Why?
|
Cytokines | 1 | 2022 | 7343 | 0.020 |
Why?
|
Ovarian Neoplasms | 1 | 2024 | 4878 | 0.020 |
Why?
|
Societies, Medical | 1 | 2019 | 3905 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2020 | 3736 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10551 | 0.020 |
Why?
|
Registries | 1 | 2021 | 8469 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14660 | 0.010 |
Why?
|
Biomedical Research | 1 | 2019 | 3426 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 2019 | 4371 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2019 | 5325 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2019 | 20080 | 0.010 |
Why?
|
Incidence | 1 | 2019 | 21392 | 0.010 |
Why?
|
Aged | 1 | 2011 | 169152 | 0.010 |
Why?
|
Concepts
(223)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(26)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_